Flip a coin until you get tails. This attack does 50 more damage for each heads.
Release year for Mega Evolution is 2025. Mega Evolution is grouped under the Mega Evolution era.
The checklist contains 188 cards, placing it in a large expansion range. As of 2026, the set is 1 year old and still in a recent release window.
In the Mega Evolution checklist, Mega Kangaskhan ex occupies position #182 as a Special Illustration Rare card.
Mega Kangaskhan ex is a Mega Evolution card from the 2025 release window. Core profile: Its card type is Pokémon.
The rarity label is Special Illustration Rare. Printed HP is 300.
Energy typing is Colorless. Card subtype classification is Basic, MEGA, and ex.
The card text reads: Mega Evolution ex Rule: When your Mega Evolution Pokémon ex is Knocked Out, your opponent takes 3 Prize cards. Notable ability on this print: "Run Errand".
Latest market snapshots place Mega Kangaskhan ex in Mega Evolution at roughly $62.74. Week-over-week change is limited (-0.9%), indicating short-term stability.
That is close to the 30-day average of $61.70. The 90-day window shows a floor near $58.40 and a peak around $70.95 (20% total spread), which maps to moderate-volatility movement.
The listed rarity for this print is Special Illustration Rare.
A wider Mega checklist helps contextualize this specific Mega Kangaskhan ex print. This comparison sample includes 3 alternatives across 2 sets.
In this sample, pricing ranges between $0.62 and $4.72 (661% total span). Relative to the alternative average ($2.02), this card is +3006%.
Notable alternatives include Mega Kangaskhan ex #25 (Mega Evolution Black Star Promos) at $0.62, Mega Kangaskhan ex #104 (Mega Evolution) at $0.72, and Mega Kangaskhan ex #164 (Mega Evolution) at $4.72.
Market structure summary: Over the last 7 days, prices have remained stable at -0.9%, indicating a consolidation phase over sudden breakouts. The 90-day range spans $58.40 to $70.95 (20% spread), which indicates moderate-volatility behavior.
Relative to the 30-day baseline ($61.70), pricing is near equilibrium. Condition sensitivity is substantial: PSA 10 carries a +134% premium over raw value.
PSA 9 is currently around $61.87, while PSA 10 is $146.68.
